Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.84%
1,092.17
+9.13
+0.84%
—1,083.041,082.631,094.711,080.59——
SIXC
Communications
SIXC
Communications
SIXC
+0.30%
604.17
+1.79
+0.30%
—602.38602.38604.24599.75——
SIXE
Energy
SIXE
Energy
SIXE
+0.70%
1,251.53
+8.70
+0.70%
—1,242.831,229.311,251.531,220.51——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.98%
1,747.78
+33.96
+1.98%
—1,713.821,715.471,754.201,715.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.23%
641.45
+1.46
+0.23%
—639.99636.98642.82631.81——
SIXR
Staples
SIXR
Staples
SIXR
+1.22%
847.69
+10.23
+1.22%
—837.46840.30852.15840.30——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.17%
216.72
+2.50
+1.17%
—214.22214.22217.26214.05——
SIXT
Technology
SIXT
Technology
SIXT
-0.42%
3,190.94
-13.44
-0.42%
—3,204.383,215.043,215.043,159.90——
SIXU
Utilities
SIXU
Utilities
SIXU
+1.94%
943.33
+17.95
+1.94%
—925.38927.91948.11927.91——
SIXV
Health care
SIXV
Health care
SIXV
+1.80%
1,468.66
+25.95
+1.80%
—1,442.711,443.011,476.181,443.01——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.34%
2,369.35
+8.01
+0.34%
—2,361.342,391.002,395.822,354.52——
NEO:NASDAQ
NeoGenomics, Inc.
$9.02
+0.67%
(+0.060) 1D
Apr 30, 11:19:52 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEO...
Open
$9.06
High
$9.36
Low
$8.85
Mkt. cap
1.19B
Avg. vol.
1.84M
Volume
578.58K
52-wk high
$13.74
52-wk low
$4.72
EPS
-$0.77
Beta
1.72
Shares outstanding
130.21M
No. of employees
2K
News stories
From sources across the web
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2.5K
Founded2002
HeadquartersFort Myers, Florida, United States
SectorHealth care provider
Websiteneogenomics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
181.33M
187.80M
190.17M
186.67M
Cost of goods sold
104.47M
107.35M
106.83M
105.81M
Cost of revenue
104.47M
107.35M
106.83M
105.81M
Research and development expenses
9.02M
8.69M
9.18M
9.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
91.36M
86.95M
86.65M
-
Operating expense
100.38M
95.64M
95.82M
99.10M
Total operating expenses
204.86M
202.99M
202.65M
204.91M
Operating income
-23.53M
-15.19M
-12.48M
-18.24M
Other non operating income
482.00K
-335.00K
84.00K
-
EBT including unusual items
-45.82M
-26.39M
-12.41M
-17.58M
EBT excluding unusual items
-21.72M
-14.57M
-11.47M
-17.58M
Income tax expense
-724.00K
740.00K
-2.52M
-472.00K
Effective tax rate
1.58%
-2.80%
20.35%
-
Other operating expenses
-
-
-
-
Net income
-45.09M
-27.13M
-9.88M
-17.11M
Net profit margin
-24.87%
-14.45%
-5.20%
-9.16%
Earnings per share
0.03
0.03
0.06
0.01
Interest and investment income
2.26M
1.56M
1.52M
1.27M
Interest expense
-933.00K
-603.00K
-599.00K
-
Net interest expenses
1.33M
960.00K
924.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.26M
1.24M
3.91M
-1.83M
Gain or loss from assets sale
-
-
31.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer